Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $86.6 million.

  • Niagen Bioscience's Shares Outstanding (Diluted Average) rose 1138.13% to $86.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.6 million, marking a year-over-year increase of 1138.13%. This contributed to the annual value of $78.1 million for FY2024, which is 418.75% up from last year.
  • According to the latest figures from Q3 2025, Niagen Bioscience's Shares Outstanding (Diluted Average) is $86.6 million, which was up 1138.13% from $86.2 million recorded in Q2 2025.
  • Niagen Bioscience's Shares Outstanding (Diluted Average)'s 5-year high stood at $86.6 million during Q3 2025, with a 5-year trough of $64.2 million in Q1 2021.
  • Over the past 5 years, Niagen Bioscience's median Shares Outstanding (Diluted Average) value was $75.0 million (recorded in 2023), while the average stood at $73.9 million.
  • In the last 5 years, Niagen Bioscience's Shares Outstanding (Diluted Average) rose by 15.97% in 2022 and then soared by 1413.73% in 2025.
  • Niagen Bioscience's Shares Outstanding (Diluted Average) (Quarter) stood at $67.2 million in 2021, then grew by 3.79% to $69.7 million in 2022, then increased by 7.54% to $75.0 million in 2023, then grew by 4.19% to $78.1 million in 2024, then increased by 10.87% to $86.6 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $86.6 million for Q3 2025, versus $86.2 million for Q2 2025 and $83.2 million for Q1 2025.